SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    C. Rae, W. Furlong, M. Jankovic, Albert Moghrabi, A. Naqvi, A. Sala, Y. Samson, S. DePauw, D. Feeny, R. Barr, Economic evaluation of treatment for acute lymphoblastic leukaemia in childhood, European Journal of Cancer Care, 2014, 23, 6
  2. 2
    Raphaële R. L. van Litsenburg, Jaap Huisman, Hein Raat, Gertjan J. L. Kaspers, Reinoud J. B. J. Gemke, Health-related quality of life and utility scores in short-term survivors of pediatric acute lymphoblastic leukemia, Quality of Life Research, 2013, 22, 3, 677

    CrossRef

  3. 3
    Ian Magrath, Eva Steliarova-Foucher, Sidnei Epelman, Raul C Ribeiro, Mhamed Harif, Chi-Kong Li, Rejin Kebudi, Scott D Macfarlane, Scott C Howard, Paediatric cancer in low-income and middle-income countries, The Lancet Oncology, 2013, 14, 3, e104

    CrossRef

  4. 4
    Raphaële R.L. van Litsenburg, Carin A. Uyl-de Groot, Hein Raat, Gertjan J.L. Kaspers, Reinoud J.B.J. Gemke, Cost-effectiveness of treatment of childhood acute lymphoblastic leukemia with chemotherapy only: The influence of new medication and diagnostic technology, Pediatric Blood & Cancer, 2011, 57, 6
  5. 5
    Alberto Redaelli, Jennifer M Stephens, Benjamin L Laskin, Chris L Pashos, Marc F Botteman, The burden and outcomes associated with four leukemias: AML, ALL, CLL and CML, Expert Review of Anticancer Therapy, 2003, 3, 3, 311

    CrossRef